Business Context and Reporting Period
This Form 8-K Current Report was filed by Phibro Animal Health Corporation on May 5, 2026. The filing reports a corporate event regarding the declaration of a quarterly cash dividend.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figure disclosed is the dividend declaration:
- Dividend Amount: $0.12 per share
- Applicable Shares: Class A Common Stock and Class B Common Stock
- Record Date: June 3, 2026
- Payment Date: June 24, 2026
Material Changes
The filing does not report material changes to financial performance, operations, or capital structure compared to prior periods. The sole material event is the new dividend declaration.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly serves to announce the dividend details referenced in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Verify the ex-dividend date (typically the trading day before the record date of June 3, 2026) to determine eligibility for the $0.12 payment.
- Confirm the total number of outstanding Class A and Class B shares to calculate the aggregate dividend payout.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the company's cash position supporting this payout.